| |
Clinilabs is a contract research organization (CRO) that provides early phase and specialty clinical drug development services to the pharmaceutical, biotechnology, and medical device industries. We focus on Phase I and Phase II studies that prepare development candidates to move forward into Phase III pivotal trials. Working within this niche, Clinilabs adds value to clinical drug development programs by executing studies that enable clients to make sound decisions regarding the viability of new drug candidates. Our goal is to move acceptable candidates forward swiftly and abandon failures early.
Clinilabs also provides specialty services not commonly offered by CROs. We offer access to specialty patient populations, investigator sites skilled in the performance of specialty procedures, and specialty data processing services that can be used in any phase of clinical drug development.
|
